Insufficient ex vivo expansion of Vα24+ natural killer T cells in malignant lymphoma patients related to the suppressed expression of CD1d molecules on CD14+ cells

Cytotherapy

Volumn 10, Issue 5, 2008, Pages 497-506

  Imataki, O ^a   Heike, Yuji ^b   Makiyama, H ^b   Iizuka, A ^b   Ikarashi, Y ^b   Ishida, T ^a   Wakasugi, H ^b   Takaue, Y ^b  

^a KAGAWA UNIVERSITY   (Japan)

^b NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

CD1d; Granulocyte colony stimulating factor; Malignant lymphoma; Natural killer T cells; galactosylceramide

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; CD14 ANTIGEN; CD1D ANTIGEN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 2; METHYLPREDNISOLONE; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; VINCRISTINE;

ADULT; ANTIGEN EXPRESSION; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CD4+ T LYMPHOCYTE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFICACY; DRUG MEGADOSE; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; LEUKAPHERESIS; LYMPHOCYTE COUNT; MALE; NATURAL KILLER T CELL; NONHODGKIN LYMPHOMA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STEM CELL EXPANSION; STEM CELL MOBILIZATION; UPREGULATION;

EID: 53249103247     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1080/14653240802072747     Document Type: Article

References (29)

1. Bendelac, A., Rivera, MN Park, SH et al. (1997) Mouse CD1-specific NK1 T cells: Development, specificity, and function. Annu Rev Immunol, 15, pp. 535-562.
2. Brossay, L., Chioda, M. Burdin, N. et al. (1998) CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution. J Exp Med, 188, pp. 1521-1528.
3. Godfrey, DI and Kronenberg, M. (2004) Going both ways: Immune regulation via CD1d-dependent NKT cells. J Clin Invest, 114, pp. 1379-1388.
4. Smyth, MJ, Thia, KY Street, SE et al. (2000) Differential tumor surveillance by natural killer (NK) and NKT cells. J Exp Med, 191, pp. 661-668.
5. Spada, FM, Koezuka, Y. and Porcelli, SA. (1998) CD1d-restricted recognition of synthetic glycolipid antigens by human natural killer T cells. J Exp Med, 188, pp. 1529-1534.
6. Kawano, T., Cui, J. Koezuka, Y. et al. (1997) CD1d-restricted and TCR-mediated activation of valpha14 NKT cells by glycosylceramides. Science, 278, pp. 1626-1629.
7. Exley, M., Garcia, J. Balk, SP et al. (1997) Requirements for CD1d recognition by human invariant Valpha24+ CD4- CD8- T cells. J Exp Med, 186, pp. 109-120.
8. Brigl, M. and Brenner, MB. (2004) CD1: Antigen presentation and T cell function. Annu Rev Immunol, 22, pp. 817-890.
9. Maeda, M., Shadeo, A. MacFadyen, AM et al. (2004) CD1d-independent NKT cells in beta 2-microglobulin-deficient mice have hybrid phenotype and function of NK and T cells. J Immunol, 172, pp. 6115-6122.
10. Van Kaer, L. (2004) Regulation of immune responses by CD1d-restricted natural killer T cells. Immunol Res, 30, pp. 139-153.
11. Toura, I., Kawano, T. Akutsu, Y. et al. (1999) Cutting edge: Inhibition of experimental tumor metastasis by dendritic cells pulsed with alpha-galactosylceramide. J Immunol, 163, pp. 2387-2391.
12. Kawano, T., Nakayama, T. Kamada, N. et al. (1999) Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res, 59, pp. 5102-5105.
13. Nieda, M., Okai, M. Tazbirkova, A. et al. (2004) Therapeutic activation of Valpha24+Vbeta11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood, 103, pp. 383-389.
14. Nieda, M., Nicol, A. Koezuka, Y. et al. (1999) Activation of human Valpha24NKT cells by alpha-glycosylceramide in a CD1d-restricted and Valpha24TCR-mediated manner. Hum Immunol, 60, pp. 10-19.
15. Takahashi, T., Nieda, M. Koezuka, Y. et al. (2000) Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol, 164, pp. 4458-4464.
16. Tahir, SM, Cheng, O. Shaulov, A. et al. (2001) Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol, 167, pp. 4046-4050.
17. Yanagisawa, K., Seino, K. Ishikawa, Y. et al. (2002) Impaired proliferative response of V alpha 24 NKT cells from cancer patients against alpha-galactosylceramide. J Immunol, 168, pp. 6494-6499.
18. Asada-Mikami, R., Heike, Y. Harada, Y. et al. (2003) Increased expansion of V alpha 24+ T cells derived from G-CSF-mobilized peripheral blood stem cells as compared to peripheral blood mononuclear cells following alpha-galactosylceramide stimulation. Cancer Sci, 94, pp. 383-388.
19. Harada, Y., Imataki, O. Heike, Y. et al. (2005) Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials. J Immunother, 28, pp. 314-321.
20. Imataki, O., Heike, Y. Ishida, T. et al. (2006) Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells. J Immunother, 29, pp. 320-327.
21. Crough, T., Purdie, DM Okai, M. et al. (2004) Modulation of human Valpha24(+)Vbeta11(+) NKT cells by age, malignancy and conventional anticancer therapies. Br J Cancer, 91, pp. 1880-1886.
22. Hoover, SK, Susskind, BM, Barrett, SK and Bear, HD. (1992) Inhibition of tumor-specific cytotoxic T-lymphocyte responses by transforming growth factor beta 1. Cancer Res, 52, pp. 1386-1392.
23. Xu, H., Chun, T. Colmone, A. et al. (2003) Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells. J Immunol, 171, pp. 4105-4112.
24. Tada, T., Ohzeki, S. Utsumi, K. et al. (1991) Transforming growth factor-beta-induced inhibition of T cell function. Susceptibility difference in T cells of various phenotypes and functions and its relevance to immunosuppression in the tumor-bearing state. J Immunol, 146, pp. 1077-1082.
25. Chouaib, S., Asselin-Paturel, C. Mami-Chouaib, F. et al. (1997) The host-tumor immune conflict: From immunosuppression to resistance and destruction. Immunol Today, 18, pp. 493-497.
26. Goto, S., Sato, M. Kaneko, R. et al. (1999) Analysis of Th1 and Th2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients. Cancer Immunol Immunother, 48, pp. 435-442.
27. Kiessling, R., Wasserman, K. Horiguchi, S. et al. (1999) Tumor-induced immune dysfunction. Cancer Immunol Immunother, 48, pp. 353-362.
28. van der Vliet, HJ, Molling, JW Nishi, N. et al. (2003) Polarization of Valpha24+ Vbeta11+ natural killer T cells of healthy volunteers and cancer patients using alpha-galactosylceramide-loaded and environmentally instructed dendritic cells. Cancer Res, 63, pp. 4101-4106.
29. Uldrich, AP, Crowe, NY Kyparissoudis, K. et al. (2005) NKT cell stimulation with glycolipid antigen in vivo: Costimulation-dependent expansion, Bim-dependent contraction, and hyporesponsiveness to further antigenic challenge. J Immunol, 175, pp. 3092-3101.